Please assess the completion status of the following clinical trial:

Trial Title: Ginger Capsules for the Acute Treatment of Migraine Attacks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
* Inclusion Criteria:~  * Migraine diagnosis for at least one year;~ * Migraine attack with moderate or severe pain intensity;~ * One to six migraine attacks per month.~* Exclusion Criteria:~  * Patients with headaches not characterized as migraine;~ * Pregnant or lactating women;~ * Fertile and sexually active women who do not use contraception;~ * Abuse of painkillers, alcohol or drugs;~ * People with hypersensitivity to ginger;~ * People with other neurological diseases;~ * People in use of anticoagulant drugs;~ * People who have started the disease after 50 years old.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Extract of ginger (Type: EXPERIMENTAL): People (both genders) who went to the emergency room of the Hospital Vera Cruz (Belo Horizonte, MG, BR) with a migraine attack received two capsules of ginger extract (containing 5% of gingerols) and intravenous ketoprofen (100mg).
- Cellulose (Type: PLACEBO_COMPARATOR): People (both genders) who went to the emergency room of the Hospital Vera Cruz (Belo Horizonte, MG, BR) with a migraine attack received two placebo capsules (cellulose) and intravenous ketoprofen (100mg).

Based on this trial design, predict the completion outcome and termination type (if applicable).